Phase II Study Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer - 101967

Spotlight
Video

Phase II Study Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer

Loading........
Description: Theodore S. Hong, MD of Massachusetts General Hospital outlines a Phase II Study of Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer at ASCO GI 2017.
Shared By : Gastrointestinal-Cancer-Meeting
Posted on : 01/26/17
Added : 2 years ago
Category : Pancreatic Cancer